Blog
RSS FeedPosted by Michael Wonder on 29 Feb 2024
House looks to weaken Medicare negotiation
29 February 2024 - Two proposals to weaken Medicare’s drug price negotiation program are getting a hearing before a House Energy ...
Posted by Michael Wonder on 29 Feb 2024
Regulator acts to close loophole enabling Australian pharmacists to make copycat Ozempic drug
29 February 2024 - The TGA will move to ban compounding pharmacists from making their own versions of injectable weight ...
Posted by Michael Wonder on 29 Feb 2024
Added benefit and revenues of oncology drugs approved by the EMA between 1995 and 2020: retrospective cohort study
28 February 2024 - Added benefit was evaluated using ratings published by seven organisations: health technology assessment agencies from the US, ...
Posted by Michael Wonder on 28 Feb 2024
Bernie Sanders wants to rein in drug prices. Is he asking the right questions?
28 February 2024 - We have a serious problem of affordability of health care in the US, including the cost of ...
Posted by Michael Wonder on 28 Feb 2024
The FDA isn’t afraid to yank a disappointing drug
26 February 2024 - The FDA is rescinding its approval of a blood cancer treatment from the Swedish firm Oncopeptides, ...
Posted by Michael Wonder on 24 Feb 2024
FDA issues final decision to withdraw approval of Pepaxto (melphalan flufenamide)
23 February 2024 - Today, the FDA announced its final decision to withdraw approval of Pepaxto (melphalan flufenamide), which was ...
Posted by Michael Wonder on 22 Feb 2024
UK's MHRA revokes authorisation for Novartis' sickle cell drug
21 February 2024 - Britain's health regulator said on Wednesday it had revoked a conditional marketing authorisation for Novartis' sickle ...
Posted by Michael Wonder on 21 Feb 2024
The Biden Administration versus Medicare Advantage
21 February 2024 - When does the failure to answer a phone call in 8 seconds cost the company receiving the ...
Posted by Michael Wonder on 21 Feb 2024
United Therapeutics starts litigation with FDA over rival Liquidia's drug application
21 February 2024 - United Therapeutics said on Wednesday it had filed a case with the US FDA, alleging that ...
Posted by Michael Wonder on 15 Feb 2024
Japan’s FY 2024 pricing reform expected to favour new listed innovative drugs
15 February 2024 - To address and maintain the financial sustainability of the national insurance system, the Government rolled out several ...
Posted by Michael Wonder on 15 Feb 2024
Launch of new HMA-EMA catalogues of real world data sources and studies
15 February 2024 - The EMA and the Heads of Medicines Agencies have launched two public electronic catalogues: one for ...
Posted by Michael Wonder on 13 Feb 2024
Federal judge tosses PhRMA lawsuit challenging Medicare drug negotiations
12 February 2024 - A Texas federal judge on Monday dismissed a lawsuit challenging the Biden administration’s Medicare drug price ...
Posted by Michael Wonder on 12 Feb 2024
House of Representatives passes bill to ban use of QALYs in federally funded health care programs
12 February 2024 - The U.S. House of Representatives passed H.R. 485, the Protecting Health Care for All Patients Act, this ...
Posted by Michael Wonder on 08 Feb 2024
In a showy hearing, Bernie Sanders gets few answers about lower drug prices
8 February 2024 - Call it Senator Bernie Sanders’ prescription drug pricing theater. ...
Posted by Michael Wonder on 08 Feb 2024
J&J, Merck and Bristol Myers CEOs defend high drug prices in Senate hearing, as Biden tries to cut costs
8 February 2024 - The CEOs of Johnson & Johnson, Merck and Bristol Myers Squibb defended high drug prices in the ...